Tag: Covaxin

New Delhi: The Indian Council of Medical Research Director General Dr Rajiv Bahl Monday criticised a recently published study on ...

New Delhi: Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' ...

New Delhi: India was able to save more than 3.4 million lives by undertaking a nationwide COVID-19 vaccination campaign at ...

New Delhi: The government has exempted customs duty on imports of Covid-19 vaccines till March 31, 2023 in a bid ...

New Delhi: Neutralising antibody responses against the SARS-COV-2 virus and its variants of concern (VoC) are higher among Covishield recipients ...

New Delhi: The Drugs Controller General of India (DCGI) approved Tuesday Bharat Biotech’s intranasal Covid-19 vaccine for restricted emergency use ...

New Delhi: India’s drug regulator, the Drugs Controller General of India (DCGI) has granted restricted emergency use authorisation (EUA) for ...

New Delhi: The Drugs Controller General of India (DCGI) Tuesday approved three Covid vaccines for the restricted emergency use authorisation ...

New Delhi: Serum Institute of India (SII) has sought emergency use authorisation (EUA) from DGCI for its Covid-19 vaccine ‘Covovax’ ...

New Delhi: As on January 30, a total of 70,102 cases of Adverse Event Following Immunisation (AEFI) and 1,013 deaths ...